U.S-based biotech company IdentifySensors, developer of graphene-based biosensors, has announced plans to commercialize its disease testing technology and seek new funding in 2026.
On its website, the Company states that its Check4™ platform…
U.S-based biotech company IdentifySensors, developer of graphene-based biosensors, has announced plans to commercialize its disease testing technology and seek new funding in 2026.
On its website, the Company states that its Check4™ platform…